Artelo Biosciences, Inc. (ARTL)
Develops drug candidates targeting lipid pathways to treat cancer, pain, neurological and psychiatric disorders.
$0.88-0.13%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-97.1%
The outlook
ARTL is trading near its 52-week low at $0.88, sitting well below both its 50-day and 200-day moving averages. Analyst coverage appears minimal or unavailable. The current data reflects a stock in a pronounced downtrend with no signs of recovery in recent price action.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$3.1M
52-wk high
$41.97
52-wk low
$0.88
50-day avg
$1.27
200-day avg
$4.56
Trailing P/E
—